/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n \n \n \n\n
\n\n \n
\n \n \n \n \n
 Recent News for Synta Pharmaceuticals Corp.\n \n\n\n\n\n
Nov 22 9:38 AM EST
\n\n\n\n
\n \n
\n \n \n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n Nov 19, 2009 6:52 AM EST
\n\n \n Trading Overview for Sinobiopharma Inc. Issued by StockPreacher.com - GlobeNewswire\n \n \n
\n\n Nov 18, 2009 8:01 AM EST
\n\n \n Synta Presents Preclinical Data on Next Generation Hsp90 Inhibitor, STA-9090 - Business Wire\n \n \n
\n\n Nov 18, 2009 8:00 AM EST
\n\n \n Synta Presents New Data on Mechanism of Action of Elesclomol at AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics - Business Wire\n \n \n
\n\n Nov 11, 2009 8:30 AM EST
\n\n \n Synta Pharmaceuticals to Present at the Lazard Capital Markets Annual Healthcare Conference - Business Wire\n \n \n
\n\n Nov 04, 2009 7:00 AM EST
\n\n \n Synta Pharmaceuticals Reports Third Quarter 2009 Financial Results - Business Wire\n \n \n
\n\n Oct 12, 2009 8:00 AM EDT
\n\n \n Synta Pharmaceuticals Announces Updated Elesclomol SYMMETRYSM Data Presented at Melanoma XIII - Business Wire\n \n \n
\n\n Oct 09, 2009 9:11 AM EDT
\n\n \n Griffin Securities Announces Investment Opinion on Targeting Cancer Stem Cells - Business Wire\n \n \n
\n
\n\n");